CRISPR And Cas Genes Market Size, Share, Trends, and Growth Outlook

CRISPR and Cas Genes Market is estimated to increase at a growth rate of 20.8% CAGR over the forecast period from 2024 to 2030.

The CRISPR and Cas Genes Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Kits & Enzymes, Vector-based Cas, DNA-free Cas, Libraries, Design Tool, Antibodies, Others), By Service (Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA synthesis), By Application (Biomedical, Agricultural), By End-user (Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, Contract Research Organizations (CROs)).

 

An Introduction to CRISPR and Cas Genes Market in 2024

The CRISPR and Cas genes market in 2024 caters to the demand for genome editing technologies and genetic engineering tools based on clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins, enabling precise modification of DNA sequences for research, biotechnology, and therapeutic applications. CRISPR-Cas systems offer versatile and efficient platforms for gene editing, gene regulation, and genetic screening, with broad applications in agriculture, drug discovery, synthetic biology, and gene therapy. Market dynamics are driven by factors such as the increasing adoption of CRISPR-based technologies, the growing investment in genome editing research and development, and advancements in CRISPR delivery methods and target specificity. Collaboration between biotechnology companies, academic researchers, and pharmaceutical firms drives innovation and market expansion in CRISPR and Cas genes, unlocking new opportunities for genome engineering and precision medicine.

 

CRISPR and Cas Genes Market Trend: Advancements in Genome Editing Technologies

A notable trend in the CRISPR and Cas Genes market is the continuous advancements in genome editing technologies. Researchers and biotech companies are exploring new applications of CRISPR-Cas systems beyond traditional gene editing, including epigenome editing, base editing, and gene regulation. Moreover, the development of novel CRISPR-associated nucleases and delivery methods is expanding the scope of genome editing capabilities, driving research efforts and commercial opportunities in diverse fields such as biotechnology, agriculture, and therapeutics.

CRISPR and Cas Genes Market Driver: Growing Demand for Precision Medicine and Therapeutic Applications

A key driver for the CRISPR and Cas Genes market is the increasing demand for precision medicine and therapeutic applications of genome editing. CRISPR-Cas technology holds immense potential for treating genetic disorders, cancer, and infectious diseases by precisely modifying DNA sequences or regulating gene expression. With advancements in CRISPR-based therapeutics, including ex vivo and in vivo gene editing approaches, there is growing interest from pharmaceutical companies, biotech startups, and academic institutions in developing novel therapies tailored to individual patient genetics, driving market growth and investment.

CRISPR and Cas Genes Market Opportunity: Expansion of CRISPR-Based Diagnostics and Research Tools

An opportunity for the CRISPR and Cas Genes market lies in the expansion of CRISPR-based diagnostics and research tools. CRISPR systems have been adapted for nucleic acid detection, enabling the development of rapid, sensitive, and specific diagnostic assays for infectious diseases, cancer biomarkers, and genetic mutations. Additionally, CRISPR-based tools such as CRISPR screens, CRISPR-mediated labeling, and CRISPR interference (CRISPRi) offer powerful capabilities for functional genomics research, target discovery, and drug development. Embracing the potential of CRISPR-based diagnostics and research tools presents an opportunity for market players to diversify their product portfolios and address unmet needs in healthcare and life sciences research.

 

CRISPR and Cas Genes Market Segmentation

By Product

Kits & Enzymes

Vector-based Cas

DNA-free Cas

Libraries

Design Tool

Antibodies

Others

By Service

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA synthesis

By Application

Biomedical

-Genome Engineering

-Disease Model Studies

-Functional Genomics

-Epigenetics

-Others

Agricultural

By End-user

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

 

CRISPR and Cas Genes Market Companies

Addgene

AstraZeneca plc

Beam Therapeutics

Caribou Biosciences Inc

Cellectis

Cibus

CRISPR Therapeutics

Danaher

Editas Medicine Inc

eGenesis

F. Hoffmann-La Roche Ltd

GenScript

Hera BioLabs

Horizon Discovery Group plc

Inscripta Inc

Intellia Therapeutics Inc

Lonza

Mammoth Biosciences

Merck KGaA

OriGene Technologies Inc

Recombinetics Inc

Synthego

Takara Bio Inc

Thermo Fisher Scientific Inc

Vertex Pharmaceuticals Inc

 

Reasons to Buy the CRISPR and Cas Genes Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the CRISPR and Cas Genes Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the CRISPR and Cas Genes Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 CRISPR and Cas Genes Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global CRISPR and Cas Genes Market Size Outlook, $ Million, 2021 to 2030

3.2 CRISPR and Cas Genes Market Outlook By Type, $ Million, 2021 to 2030

3.3 CRISPR and Cas Genes Market Outlook By Product, $ Million, 2021 to 2030

3.4 CRISPR and Cas Genes Market Outlook By Application, $ Million, 2021 to 2030

3.5 CRISPR and Cas Genes Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of CRISPR and Cas Genes Market Industry

4.2 Key Market Trends in CRISPR and Cas Genes Market Industry

4.3 Potential Opportunities in CRISPR and Cas Genes Market Industry

4.4 Key Challenges in CRISPR and Cas Genes Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global CRISPR and Cas Genes Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global CRISPR and Cas Genes Market Outlook By Segments

7.1 CRISPR and Cas Genes Market Outlook by Segments

By Product

Kits & Enzymes

Vector-based Cas

DNA-free Cas

Libraries

Design Tool

Antibodies

Others

By Service

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA synthesis

By Application

Biomedical

-Genome Engineering

-Disease Model Studies

-Functional Genomics

-Epigenetics

-Others

Agricultural

By End-user

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

 

8 North America CRISPR and Cas Genes Market Analysis And Outlook To 2030

8.1 Introduction to North America CRISPR and Cas Genes Markets in 2024

8.2 North America CRISPR and Cas Genes Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America CRISPR and Cas Genes Market size Outlook by Segments, 2021-2030

By Product

Kits & Enzymes

Vector-based Cas

DNA-free Cas

Libraries

Design Tool

Antibodies

Others

By Service

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA synthesis

By Application

Biomedical

-Genome Engineering

-Disease Model Studies

-Functional Genomics

-Epigenetics

-Others

Agricultural

By End-user

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

 

9 Europe CRISPR and Cas Genes Market Analysis And Outlook To 2030

9.1 Introduction to Europe CRISPR and Cas Genes Markets in 2024

9.2 Europe CRISPR and Cas Genes Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe CRISPR and Cas Genes Market Size Outlook By Segments, 2021-2030

By Product

Kits & Enzymes

Vector-based Cas

DNA-free Cas

Libraries

Design Tool

Antibodies

Others

By Service

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA synthesis

By Application

Biomedical

-Genome Engineering

-Disease Model Studies

-Functional Genomics

-Epigenetics

-Others

Agricultural

By End-user

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

 

10 Asia Pacific CRISPR and Cas Genes Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific CRISPR and Cas Genes Markets in 2024

10.2 Asia Pacific CRISPR and Cas Genes Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific CRISPR and Cas Genes Market size Outlook by Segments, 2021-2030

By Product

Kits & Enzymes

Vector-based Cas

DNA-free Cas

Libraries

Design Tool

Antibodies

Others

By Service

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA synthesis

By Application

Biomedical

-Genome Engineering

-Disease Model Studies

-Functional Genomics

-Epigenetics

-Others

Agricultural

By End-user

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

 

11 South America CRISPR and Cas Genes Market Analysis And Outlook To 2030

11.1 Introduction to South America CRISPR and Cas Genes Markets in 2024

11.2 South America CRISPR and Cas Genes Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America CRISPR and Cas Genes Market size Outlook by Segments, 2021-2030

By Product

Kits & Enzymes

Vector-based Cas

DNA-free Cas

Libraries

Design Tool

Antibodies

Others

By Service

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA synthesis

By Application

Biomedical

-Genome Engineering

-Disease Model Studies

-Functional Genomics

-Epigenetics

-Others

Agricultural

By End-user

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

 

12 Middle East And Africa CRISPR and Cas Genes Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa CRISPR and Cas Genes Markets in 2024

12.2 Middle East and Africa CRISPR and Cas Genes Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa CRISPR and Cas Genes Market size Outlook by Segments, 2021-2030

By Product

Kits & Enzymes

Vector-based Cas

DNA-free Cas

Libraries

Design Tool

Antibodies

Others

By Service

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA synthesis

By Application

Biomedical

-Genome Engineering

-Disease Model Studies

-Functional Genomics

-Epigenetics

-Others

Agricultural

By End-user

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Addgene

AstraZeneca plc

Beam Therapeutics

Caribou Biosciences Inc

Cellectis

Cibus

CRISPR Therapeutics

Danaher

Editas Medicine Inc

eGenesis

F. Hoffmann-La Roche Ltd

GenScript

Hera BioLabs

Horizon Discovery Group plc

Inscripta Inc

Intellia Therapeutics Inc

Lonza

Mammoth Biosciences

Merck KGaA

OriGene Technologies Inc

Recombinetics Inc

Synthego

Takara Bio Inc

Thermo Fisher Scientific Inc

Vertex Pharmaceuticals Inc

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

CRISPR and Cas Genes Market Segmentation

By Product

Kits & Enzymes

Vector-based Cas

DNA-free Cas

Libraries

Design Tool

Antibodies

Others

By Service

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA synthesis

By Application

Biomedical

-Genome Engineering

-Disease Model Studies

-Functional Genomics

-Epigenetics

-Others

Agricultural

By End-user

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)